BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 24320414)

  • 1. Source position verification and dosimetry in HDR brachytherapy using an EPID.
    Smith RL; Taylor ML; McDermott LN; Haworth A; Millar JL; Franich RD
    Med Phys; 2013 Nov; 40(11):111706. PubMed ID: 24320414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The feasibility study and characterization of a two-dimensional diode array in "magic phantom" for high dose rate brachytherapy quality assurance.
    Espinoza A; Beeksma B; Petasecca M; Fuduli I; Porumb C; Cutajar D; Corde S; Jackson M; Lerch ML; Rosenfeld AB
    Med Phys; 2013 Nov; 40(11):111702. PubMed ID: 24320410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of a 2D diode array in "magic phantom" for use in high dose rate brachytherapy pretreatment quality assurance.
    Espinoza A; Petasecca M; Fuduli I; Howie A; Bucci J; Corde S; Jackson M; Lerch ML; Rosenfeld AB
    Med Phys; 2015 Feb; 42(2):663-673. PubMed ID: 28102606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated system for clinical treatment verification of HDR prostate brachytherapy combining source tracking with pretreatment imaging.
    Smith RL; Hanlon M; Panettieri V; Millar JL; Matheson B; Haworth A; Franich RD
    Brachytherapy; 2018; 17(1):111-121. PubMed ID: 28958735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for verification of treatment delivery in HDR prostate brachytherapy using a flat panel detector for both imaging and source tracking.
    Smith RL; Haworth A; Panettieri V; Millar JL; Franich RD
    Med Phys; 2016 May; 43(5):2435. PubMed ID: 27147354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with EPID dosimetry for prostate IMRT pre-treatment dose verification.
    McDermott LN; Wendling M; van Asselen B; Stroom J; Sonke JJ; van Herk M; Mijnheer BJ
    Med Phys; 2006 Oct; 33(10):3921-30. PubMed ID: 17089854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and use of a 2D-array of ion chambers for brachytherapy dosimetric quality assurance.
    Yewondwossen M
    Med Dosim; 2012; 37(3):250-6. PubMed ID: 22189031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A BrachyPhantom for verification of dose calculation of HDR brachytherapy planning system.
    Austerlitz C; Campos CA
    Med Phys; 2013 Nov; 40(11):112103. PubMed ID: 24320456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verification of treatment parameter transfer by means of electronic portal dosimetry.
    Nijsten SM; Minken AW; Lambin P; Bruinvis IA
    Med Phys; 2004 Feb; 31(2):341-7. PubMed ID: 15000620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A literature review of electronic portal imaging for radiotherapy dosimetry.
    van Elmpt W; McDermott L; Nijsten S; Wendling M; Lambin P; Mijnheer B
    Radiother Oncol; 2008 Sep; 88(3):289-309. PubMed ID: 18706727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of a 2D diode array in “magic phantom” for use in high dose rate brachytherapy pretreatment quality assurance.
    Espinoza A; Petasecca M; Fuduli I; Howie A; Bucci J; Corde S; Jackson M; Lerch ML; Rosenfelda AB
    Med Phys; 2015 Feb; 42(2):663-73. PubMed ID: 25771556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 3D dose distributions for HDR 192Ir brachytherapy sources with normoxic polymer gel dosimetry and treatment planning system.
    Senkesen O; Tezcanli E; Buyuksarac B; Ozbay I
    Med Dosim; 2014; 39(3):266-71. PubMed ID: 24933316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment verification of IMRT absolute dose distributions using a commercial a-Si EPID.
    Talamonti C; Casati M; Bucciolini M
    Med Phys; 2006 Nov; 33(11):4367-78. PubMed ID: 17153415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-axis dose response characteristics of an amorphous silicon electronic portal imaging device.
    Greer PB
    Med Phys; 2007 Oct; 34(10):3815-24. PubMed ID: 17985627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verification of the plan dosimetry for high dose rate brachytherapy using metal-oxide-semiconductor field effect transistor detectors.
    Qi ZY; Deng XW; Huang SM; Lu J; Lerch M; Cutajar D; Rosenfeld A
    Med Phys; 2007 Jun; 34(6):2007-13. PubMed ID: 17654904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High resolution small-scale inorganic scintillator detector: HDR brachytherapy application.
    Debnath SBC; Ferre M; Tonneau D; Fauquet C; Tallet A; Goncalves A; Darreon J
    Med Phys; 2021 Apr; 48(4):1485-1496. PubMed ID: 33476399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of commercial MOSFET detectors and their feasibility for in-vivo HDR brachytherapy.
    Phurailatpam R; Upreti R; Nojin Paul S; Jamema SV; Deshpande DD
    Phys Med; 2016 Jan; 32(1):208-12. PubMed ID: 26470807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of EPID transit dosimetry based on a through-air dosimetry algorithm.
    Berry SL; Sheu RD; Polvorosa CS; Wuu CS
    Med Phys; 2012 Jan; 39(1):87-98. PubMed ID: 22225278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurate two-dimensional IMRT verification using a back-projection EPID dosimetry method.
    Wendling M; Louwe RJ; McDermott LN; Sonke JJ; van Herk M; Mijnheer BJ
    Med Phys; 2006 Feb; 33(2):259-73. PubMed ID: 16532930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a novel EPID designed for simultaneous imaging and dose verification in radiotherapy.
    Blake SJ; McNamara AL; Deshpande S; Holloway L; Greer PB; Kuncic Z; Vial P
    Med Phys; 2013 Sep; 40(9):091902. PubMed ID: 24007153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.